


The Fund aims to provide a combination of income and long term capital growth.
| Name | % Net Assets |
|---|---|
| HSBC HLDGS | 8.0% |
| ROYAL DUTCH SHELL | 7.5% |
| Glaxosmithkline | 7.1% |
| BP | 5.0% |
| Vodafone Group | 4.4% |
| Signet Jewelers Ltd | 4.1% |
| Astrazeneca | 3.9% |
| Unilever | 3.7% |
| Travis Perkins | 3.2% |
| British American Tobacco | 2.8% |
| Key | % Net Assets |
|---|---|
| 8.0% | |
| 7.5% | |
| 7.1% | |
| 5.0% | |
| 72.4% |
| Date | 01-Mar-2019 |
|---|---|
| NAV | 1,380.98p |
| Currency | GBP |
| Change | 18.25p |
| % | 1.34% |
| YTD change | 1,380.98p |
| YTD % | n/a |
| Fund Inception | 02/10/1978 |
|---|---|
| Fund Manager | n/a |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £100000000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 6.00% |
| Annual Mang't | n/a |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research